ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 49 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,431,000 | +1.3% | 3,332,616 | -10.1% | 2.35% | -47.1% |
| Q4 2019 | $10,300,000 | +714.2% | 3,705,128 | +509.2% | 4.44% | +1141.3% |
| Q2 2019 | $1,265,000 | -56.1% | 608,151 | -24.4% | 0.36% | -65.4% |
| Q1 2019 | $2,880,000 | -52.5% | 804,446 | -49.2% | 1.04% | -62.8% |
| Q4 2018 | $6,060,000 | -76.0% | 1,582,275 | -40.9% | 2.78% | -66.5% |
| Q3 2018 | $25,296,000 | +30.7% | 2,676,825 | +0.9% | 8.29% | +25.7% |
| Q2 2018 | $19,358,000 | +160.7% | 2,651,825 | +78.5% | 6.60% | +114.3% |
| Q1 2018 | $7,426,000 | +877.1% | 1,485,245 | +886.3% | 3.08% | +477.7% |
| Q4 2017 | $760,000 | – | 150,592 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,651,825 | $19,358,000 | 6.60% |
| RTW INVESTMENTS, LP | 5,165,499 | $37,708,000 | 2.72% |
| Eversept Partners, LP | 97,495 | $711,714 | 0.33% |
| Seelaus Asset Management LLC | 14,300 | $104,000 | 0.09% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,765,315 | $8,827,000 | 0.08% |
| ALGERT GLOBAL LLC | 34,816 | $254,000 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 48,000 | $350,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 211,115 | $1,540,000 | 0.03% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,000,400 | $29,203,000 | 0.02% |
| PDT Partners, LLC | 66,965 | $489,000 | 0.02% |